Regarding ordinary General Meeting of Shareholders, the agenda

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Regarding ordinary General Meeting of Shareholders, the agenda and draft resolutions

Telšiai, Lietuva, 2015-04-03 16:00 CEST (GLOBE NEWSWIRE) -- By the initiative and resolution of the Board of AB Žemaitijos pienas an ordinary General Meeting of Shareholders of AB Žemaitijos pienas (registered office at Sedos str. 35, Telšiai, company code 180240752), is convened on 24 April 2015.

Venue – Meeting room of AB Žemaitijos pienas located at Sedos str. 35, Telšiai.

Time – 3 p.m. (Registration starts at 2.30 p.m.).

The date of identification – 20 April 2015 (the right to attend and vote at the General Meeting of Shareholders is entitled only to those persons who are shareholders of the Company as of the end of the said identification date, or their authorized representatives, or the persons with whom an agreement on the disposal of the voting rights is concluded ).

The proposed Meeting agenda and draft resolution (attached).

The Company shall not enable participating and voting at the Meeting by electronic means of communication.

Shareholders who hold shares carrying at least 1/20 of all votes, as well as other persons specified by law may propose annexes to issues on the agenda, by providing a draft resolution of the General Meeting to every proposed additional issue, or in case no resolution is required – an explanation. The proposals to annex the agenda shall be submitted in writing.

The proposals to annex the agenda with the additional issues may be submitted following the terms of the Law on Companies of the Republic of Lithuania.

  The shareholders have the right to submit the questions related to the Meeting agenda beforehand. The shareholders may submit the questions by e-mail not later than 3 working days before the Meeting. The Company shall answer the questions submitted by e-mail before the Meeting. In case the relevant information is posted on the Company's website – http://www.zpienas.lt, the Company shall not provide the shareholder with a personal reply.

During the registration to attend the Meeting, the shareholders or their authorized representatives shall present a document confirming personal identity. The authorized representatives must provide powers of attorney duly endorsed as provided by the law. A power of attorney issued by a natural person must be notarized. A power of attorney issued in a foreign state must be translated into Lithuanian and legalized as provided by the law. The representative may be authorized by more than one shareholder and vote differently under the orders of each shareholder. The form of the power of attorney is not specified by the Company.

  Shareholder, holding shares in the Company in his own name, but for the benefit of other persons, before voting at the General Meeting, shall disclose the identity of the final customer, the number of shares that are put to the vote and the content of the voting instructions submitted to him or any other explanation regarding the participation agreed upon with the customer and voting at the General Meeting. Because of votes carried by this part of shares, a shareholder may vote differently from the rest of votes attached to the shares.

The shareholders are also entitled with other rights and obligations as provided in the Law on Companies of the Republic of Lithuania and / or other legislation.

         Gintaras Keliauskas, Lawyer,          Phone + 370444 22208

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 101

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 10

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 111

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Tigo Energy Faces Lawsuit: Key Details for Investors

Updated Category News Views 49

Tigo Energy Inc.'s Troubles: A Stock Drop and Legal Woes You see, not every day do you wake up to find your investment taking a nose dive by 36.76%. But that’s exactly what happened to Tigo Energy, Inc. (NASDAQ: TYGO) after some shaky announcements. A Rollercoaster for Investors On August 4, 2026, Tigo hit investors with a one-two punch: revised financial outlook and...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 19

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Pollo AI Unveils York AI: Automating Social Growth

Updated Category News Views 234

York AI Debuts as the New Kid on the Block Amid the hustle and bustle of a tech-savvy Singapore, Pollo AI’s latest offering, York AI, sashays onto the scene with the promise of putting social media growth on cruise control. We're talking about a digital sidekick that seems to know your online persona better than you do. It’s tailored for everyone from the small-time...

Continue Reading
Life Insurance: Evolving with Your Financial Journey

Updated Category News Views 32

Why Life Insurance Isn't Just a 'Set It and Forget It' Life insurance isn't some one-time deal you lock in and toss aside. Mike Newell, an insurance pro, highlights how life's shifts—whether in income, dependents, or debt—should drive tweaks to your coverage. As your life story unfolds, so too should the backbone of your financial security. Early Adulthood: Setting...

Continue Reading
Sinch Appoints Jonas Dahlberg as New CEO: A Strategic Move

Updated Category News Views 0

A Change at the Helm: Dahlberg Takes Charge Here we go, folks—Sinch, that global powerhouse in customer communications, just got itself a new captain. Jonas Dahlberg is now officially the CEO, after warming the acting CEO seat since June. This ain't your ordinary office shuffle. It's a calculated chess move in the high-stakes tech world. Dahlberg's Path to the Top This...

Continue Reading
LONGWELL's New Axial Fan Selection Guide Unveiled

Updated Category News Views 75

LONGWELL's New Fan Brochure Shakes Up Data Center Cooling Alright, let's cut to the chase. LONGWELL, the folks out in Ningbo who live and breathe HVACR and industrial fans, have dropped a new tool that’s going to have OEM engineers raising a glass. This twelve-page axial fan selection guide is a stroke of genius—or at least that's what those of us who've braved the...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 162

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles